Tamoxifen 40 - Stealth Labs

Tamoxifen citrate, synthesized by ICI in 1962, marked a turning point in hormonal therapy. Initially rejected as a contraceptive, it gained new purpose when its estrogen-blocking properties were discovered. The compound was approved in 1977 as Nolvadex for treating estrogen-sensitive breast cancers, where it became a standard therapy. It later entered performance-enhancement circles as a method for reducing gynecomastia and supporting endogenous testosterone restoration during post-cycle therapy.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Tamoxifen 40 by Stealth Labs, consult with your doctor or healthcare professional.